CLVT Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-03-31: Revenue $585.50M ; Cost of revenue $192.10M ; Selling, general and administrative $176.30M ; Operating expenses (m) . 2025-12-31: Revenue $617.00M* ; Cost of revenue $204.80M* ; Selling, general and administrative $179.10M* ; Operating expenses (m) . 2025-09-30: Revenue $623.10M ; Cost of revenue $218.20M ; Selling, general and administrative $170.00M ; Operating expenses (m) . 2025-06-30: Revenue $621.40M ; Cost of revenue $203.60M ; Selling, general and administrative $181.10M ; Operating expenses (m) . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
CLVT revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Re Occurring Revenues $109.30M Recurring Revenues $512.60M Subscription Revenues $403.30M Transactional Revenues $74.70M Revenue $587.30M Cost of revenue $185.50M Operating income -$200.20M Selling, general & administrative $181.60M Pre-tax income -$260.60M Income tax $8.00M Net income -$268.60M
Segment Separate filed amounts; connecting flows are not established. Components and totals may overlap.
CLVT revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Academia Government Group $300.30M Intellectual Property Group $198.30M Life Sciences And Healthcare Group $88.70M Revenue $587.30M Cost of revenue $185.50M Operating income -$200.20M Selling, general & administrative $181.60M Pre-tax income -$260.60M Income tax $8.00M Net income -$268.60M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Selling, general and administrative Operating expenses Income tax Net income 2026-03-31 $585.50M $192.10M $176.30M (m) $11.40M -$40.20M 2025-12-31 $617.00M* $204.80M* $179.10M* (m) -$27.70M* $3.10M* 2025-09-30 $623.10M $218.20M $170.00M (m) $3.80M -$28.30M 2025-06-30 $621.40M $203.60M $181.10M (m) $12.30M -$72.00M 2025-03-31 $593.70M $207.00M $178.40M (m) $18.80M -$103.90M 2024-09-30 $622.20M $210.10M $169.70M (m) $15.10M -$65.60M 2024-06-30 $650.30M $213.60M $185.20M (m) -$6.80M -$304.30M 2024-03-31 $621.20M $217.80M $191.90M (m) $15.00M -$75.00M 2023-09-30 $647.20M $220.60M $171.90M (m) $15.60M $12.30M 2023-06-30 $668.80M $224.20M $192.90M (m) -$35.30M -$123.10M 2023-03-31 $629.10M $229.70M $194.80M (m) -$63.60M $43.50M 2022-09-30 $635.70M $223.70M $169.50M (m) $22.10M -$4.42B 2022-06-30 $686.60M $244.10M $186.10M (m) $10.50M $62.40M 2022-03-31 $662.20M $249.20M $193.70M (m) $16.30M $69.50M 2021-12-31 $560.70M (m) (m) (m) (m) (m) 2021-09-30 $442.12M $140.70M $144.80M (m) $3.70M $28.40M 2021-06-30 $445.64M $149.70M $179.70M (m) $8.20M -$131.50M 2021-03-31 $428.43M $147.90M $134.30M $497.94M $300.00K -$56.00M 2020-12-31 $455.60M (m) (m) (m) (m) -$13.72M 2020-09-30 $284.36M $93.55M $131.53M $297.02M $4.33M -$181.99M 2020-06-30 $273.50M $92.38M $103.67M $259.25M -$5.38M -$25.28M 2020-03-31 $240.59M (m) $133.06M $268.90M $14.75M -$129.63M 2019-12-31 $255.01M (m) (m) (m) (m) -$84.42M 2019-09-30 $243.00M (m) $115.52M $246.55M $1.64M -$11.01M 2019-06-30 $242.31M (m) $154.15M $278.89M $3.71M -$103.95M 2019-03-31 $234.03M (m) $92.30M $259.94M $240.00K -$59.26M 2018-12-31 $245.25M (m) (m) (m) (m) -$43.45M 2018-09-30 $242.90M (m) (m) (m) (m) -$54.73M 2018-06-30 $243.30M (m) (m) (m) (m) -$66.94M 2018-03-31 $237.03M (m) (m) (m) (m) -$77.04M
Revenue and expense 6 month Period end Revenue Cost of revenue Selling, general and administrative Operating expenses Income tax Net income 2025-06-30 $1.22B $410.60M $359.50M (m) $31.10M -$175.90M 2024-06-30 $1.27B $431.40M $377.10M (m) $8.20M -$379.30M 2023-06-30 $1.30B $453.90M $387.70M (m) -$98.90M -$79.60M 2022-06-30 $1.35B $493.30M $379.80M (m) $26.80M $131.90M 2021-06-30 $874.10M $297.60M $314.00M (m) $8.50M -$187.50M 2020-06-30 $514.09M $175.06M $236.72M $528.15M $9.37M -$154.91M 2019-06-30 $476.33M (m) $261.10M $538.83M $3.95M -$163.21M
Revenue and expense 9 month Period end Revenue Cost of revenue Selling, general and administrative Operating expenses Income tax Net income 2025-09-30 $1.84B $628.80M $529.50M (m) $34.90M -$204.20M 2024-09-30 $1.89B $641.50M $546.80M (m) $23.30M -$444.90M 2023-09-30 $1.95B $674.80M $559.30M (m) -$83.30M -$67.30M 2022-09-30 $1.98B $717.00M $549.30M (m) $48.90M -$4.28B 2021-09-30 $1.32B $438.30M $458.80M (m) $12.20M -$159.10M 2020-09-30 $798.45M $268.61M $368.25M $825.18M $13.69M -$336.90M 2019-09-30 $719.33M (m) $376.61M $785.39M $5.60M -$174.21M
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-12-31 $2.46B $833.60M (m) $708.60M (m) $7.20M -$201.10M 2024-12-31 $2.56B $869.20M (m) $727.60M (m) $82.90M -$636.70M 2023-12-31 $2.63B $906.40M (m) $739.70M (m) -$101.30M -$911.20M 2022-12-31 $2.66B $954.00M (m) $729.90M (m) -$28.90M -$3.96B 2021-12-31 $1.88B $626.10M (m) $643.00M (m) $12.30M -$270.50M 2020-12-31 $1.25B $438.80M (m) $544.70M $1.29B -$2.70M -$350.60M 2019-12-31 $974.35M $352.00M (m) $475.01M $1.06B $10.20M -$258.63M 2018-12-31 $968.47M (m) $13.71M $413.00M $1.07B $5.65M -$242.16M 2017-12-31 $917.63M (m) $17.66M $343.14M $1.06B -$21.29M -$263.93M